NCT06045364View on ClinicalTrials.gov

Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

July 20, 2024

Study Completion Date

July 31, 2024

Conditions
Nausea and Vomiting
Interventions
DRUG

Glycopyrrolate

During induction of anesthesia, 0.2mg Glycopyrrolate was given intravenously

DRUG

Anisodamine

During induction of anesthesia,10mg of Anisodamine was given intramuscular injection.

Trial Locations (1)

400000

The Second Affiliated Hospital Of Chongqing Medical University, Chongqing

All Listed Sponsors
lead

Jie Chen

OTHER

NCT06045364 - Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation | Biotech Hunter | Biotech Hunter